Thanks to everyone that has donated, we have reached 36% of our goal so far. We have two weeks left in our crowdfunding campaign, and we appreciate all of the help that you have given us! Here is a brief update of what we've been up to for the past week.
In the drylab, we have finalized our design of the treatment applicator: a model of the design is attached to this update. The tip of the applicator is shown in white, and acts as a refillable medication administration port for our treatment, which is represented here as a purple gel. This parenteral mechanism of treatment administration provides the novel possibility to double as a fish tag and allows for repeated administration of treatments through the applicator.
There has been equally good news in the wetlab this week! By utilizing conjugation of engineered vector plasmids, we have successfully engineered a strain of E. coli that is currently serving as a "cellular factory" for the production of an ecnB phenotype, which is the toxin peptide that we have found to target and destroy F. psychrophilum, the bacterium responsible for Bacterial Cold Water Disease.
Through our outreach efforts, we have continued our involvement with YOURS (Youth Outreach Undergraduates Reshaping Success), in which we have worked to expose children and adolescents from disadvantaged economic backgrounds to the sciences. We will also be visiting Bath Hatchery in Bath, NY, in order to get additional feedback on our Bacterial Cold Water Disease treatment and medication administration device.
This was certainly a very busy week for us, and again, we greatly appreciate all of the help that you have provided!